title: Rapid sequential gain of ABL1 kinase domain mutations with a complex karyotype in the progression of chronic myelogenous leukemia.
authors.affiliation: Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
authors.forename: Yousun
authors.initials: Y
authors.lastname: Chung
authors.affiliation: Hematologic Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
authors.forename: Hyeon-Seok
authors.initials: HS
authors.lastname: Eom
authors.affiliation: Hematologic Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
authors.forename: Hyewon
authors.initials: H
authors.lastname: Lee
authors.affiliation: Hematologic Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
authors.forename: Sunseob
authors.initials: S
authors.lastname: Park
authors.affiliation: Department of Laboratory Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
authors.forename: Hyoeun
authors.initials: H
authors.lastname: Shim
authors.affiliation: Greencross Reference Laboratory, Yongin, Korea.
authors.forename: Eun Hae
authors.initials: EH
authors.lastname: Cho
authors.affiliation: Department of Laboratory Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
authors.forename: Sun-Young
authors.initials: SY
authors.lastname: Kong
mesh_terms: D001483:Base Sequence; D001549:Benzamides / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D000069439:Dasatinib; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics*; D008875:Middle Aged; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D017422:Sequence Analysis, DNA; D013844:Thiazoles / Q000627:therapeutic use; D014178:Translocation, Genetic
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl; D000069439:Dasatinib